Applications of 5-Bromonicotinamide in Industrial Manufacturing

As a specialized manufacturer of 5-Bromonicotinamide, we support downstream producers in advanced chemical synthesis with consistent quality. This intermediate stands out in key industrial segments requiring fine control of pyridine ring bromination. Below, we outline practical application scenarios based on established market adoption, formulation data, and our customers’ process integration needs.

1. Pharmaceutical API Intermediate for Nicotinamide Derivatives

Pharmaceutical synthesis utilizes 5-Bromonicotinamide primarily for constructing specific aminopyridine cores in highly regulated small-molecule APIs. Drug manufacturers employ this material in stepwise bromination that precedes targeted amination reactions, supporting the development of second-generation nicotinamide analogs for anti-inflammatory and metabolic disorder treatments. Quality assurance depends on maintaining trace impurities below pharmacopeial thresholds through robust input material control.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
• USP, EP, and JP monographs for related substances and purity criteria
• DMF (Drug Master File) referencing requirements for regulated jurisdictions
• 21 CFR Part 211 cGMP for finished pharmaceuticals (impacting intermediate traceability)

Typical usage ratio

• 5-Bromonicotinamide typically represents 8–14% of the total input mass in multi-step syntheses, with precise ratio changes based on target compound yield and the presence of residual reactants; QC teams determine adjustments batchwise via HPLC assay.

Downstream process integration

• The material enters the process at the bromination or amination step in the multi-stage route; most often, it reacts with nucleophilic reagents under temperature-controlled, sealed-vessel conditions, followed by purification via crystallization or extraction.

Final product types

• Regulated Active Pharmaceutical Ingredients (e.g., Nicotinamide analogs for oral or injectable dosage forms)
• Advanced intermediates for metabolic or cardiovascular pharmaceutical products
• Building blocks for patent-protected drug candidates

2. Agrochemical Intermediate Supply for Pyridine-Based Herbicides

Cropping science formulators use 5-Bromonicotinamide for the selective synthesis of heterocyclic seeds integral to next-generation herbicide products. It acts as a core halogenated pyridine structure, uniquely suited to further chlorination, methylation, or cross-coupling reactions in the fabrication of high-crop-safety actives. Ensuring batch-to-batch consistency minimizes downstream synthetic impurities in compliance with global agrochemical residue standards.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products (active content and impurity limits)
• ISO 9001:2015 Quality Management for agro-intermediates
• China GB/T 1601-2008: Agrochemical Intermediates Quality Standard
• REACH Registration (EU) for chemical substance management

Typical usage ratio

• Dosage rates in agrochemical technical-grade production run from 3–7% by mass, calculated per synthesis batch size and the complexity of target molecules; most users pilot ratios at bench-scale prior to scale-up.

Downstream process integration

• The compound is introduced at the heterocyclic framework assembly stage, typically via direct halogen exchange or Suzuki coupling with arylboronic acids, and subsequently purified to remove brominated byproducts prior to herbicide formulation.

Final product types

• Pyridine-based herbicide active ingredients for post-emergence weed control
• Intermediate compounds for combination formulations used in broad-acre applications
• Standard reference materials for residue analysis programs

3. Veterinary Drug Intermediate for Modified Vitamin B3 Analogs

Manufacturers of veterinary medicines incorporate 5-Bromonicotinamide in the custom synthesis of vitamin B3 (niacinamide) derivatives, aiming to modulate bioavailability and palatability for feed and oral treatments in farm animals. Stringent veterinary sector regulations on feed additive origins and safety drive demand for traceable, bromine-specific intermediates ensuring final product purity and performance.

Industry compliance standards

• VICH GL3 GMP for Veterinary Drug Substances
• EU Regulation (EC) No. 470/2009 for veterinary medicinal products
• FDA Feed Additive Petition (FAP) guidelines for animal drug ingredients
• China Ministry of Agriculture Safety Standards for Feed Additives (NY/T 1393-2007)

Typical usage ratio

• Formulators introduce the intermediate at 2–6% by total synthesis inputs, varying by desired analog and reaction pathway selectivity; process teams optimize this based on TLC and GC-MS benchmarks per target impurity thresholds.

Downstream process integration

• The compound is incorporated at the ring functionalization or amidation step, most commonly followed by hydrogenation or alkylation stages that determine vitamin analog properties relevant to ruminant and monogastric absorption profiles.

Final product types

• Vitamin B3 analogs for livestock and poultry feed additives
• Modified niacinamide veterinary active agents
• Animal health oral solutions and boluses in the veterinary sector

4. Organic Synthesis Intermediate for Electronic Chemical Materials

The electronics industry leverages 5-Bromonicotinamide for downstream manufacturing of specialty pyridine-containing building blocks, essential for functional polymer synthesis, organic semiconductors, and fine-tuned photoresist materials. Processors demand ultra-low metallic and halide ion impurities, testing each batch for compatibility with semiconductor fabrication lines and microelectronic-grade formulations.

Industry compliance standards

• IEC 60747 (International Standard for Semiconductor Devices)
• SEMI C3 Standard for High-Purity Electronic Chemicals
• China SJ/T 11363-2006: Electronic Grade Chemical Material Specifications
• QC consistent with IPC-4101 (for high performance laminates and prepregs)

Typical usage ratio

• Input proportions range from 1.5–5% by weight in custom organic synthesis, determined by final electronic material required and measured for impact on polymer performance; trace metal and halogen limits are specified below 10 ppm for this application.

Downstream process integration

• The intermediate is employed at the halogenated monomer or crosslinker introduction stage, frequently via solution-phase aryl coupling or controlled polymerization setups, followed by multi-stage purification for electronics-grade cleanroom use.

Final product types

• Functionalized pyridine monomers for conductive polymers
• Specialty organic semiconductors
• Photolithography photoresist precursors
• High-purity microelectronic component chemicals